| 000 | 01283 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250517034510.0 | ||
| 264 | 0 | _c20160318 | |
| 008 | 201603s 0 0 eng d | ||
| 022 | _a1874-1754 | ||
| 024 | 7 |
_a10.1016/j.ijcard.2015.05.156 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabos, Christopher | |
| 245 | 0 | 0 |
_aPlacing HPS2-THRIVE in context using Bayesian analysis. _h[electronic resource] |
| 260 |
_bInternational journal of cardiology _cSep 2015 |
||
| 300 |
_a203-4 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 | _aBayes Theorem |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xcomplications |
| 650 | 0 | 4 | _aDelayed-Action Preparations |
| 650 | 0 | 4 |
_aDyslipidemias _xcomplications |
| 650 | 0 | 4 |
_aFlushing _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndoles _xadministration & dosage |
| 650 | 0 | 4 |
_aLipid Regulating Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aNiacin _xadministration & dosage |
| 650 | 0 | 4 |
_aProstaglandin D2 _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aRisk Assessment _xmethods |
| 700 | 1 | _aBrophy, James M | |
| 700 | 1 | _aThanassoulis, George | |
| 773 | 0 |
_tInternational journal of cardiology _gvol. 195 _gp. 203-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijcard.2015.05.156 _zAvailable from publisher's website |
| 999 |
_c24956692 _d24956692 |
||